NCT01939184

Brief Summary

The purpose of this study is to evaluate the safety and efficacy of various fixed daily doses of WC3055 compared with placebo for the treatment of subjects with LUTS secondary to BPH.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
796

participants targeted

Target at P75+ for phase_2

Timeline
Completed

Started Aug 2013

Shorter than P25 for phase_2

Geographic Reach
1 country

95 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2013

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

September 4, 2013

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 11, 2013

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2014

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2014

Completed
Last Updated

June 29, 2015

Status Verified

June 1, 2015

Enrollment Period

7 months

First QC Date

September 4, 2013

Last Update Submit

June 1, 2015

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change from Baseline in Total IPSS (International Prostate Symptom Score)

    Sum of Questions 1-7.

    Final Visit (Week 12 or final visit)

Secondary Outcomes (6)

  • Change from Baseline Total IPSS

    Week 4

  • Change from Baseline Total IPSS

    Week 8

  • Change from Baseline IIEF-EF (International Index of Erectile Function-Erectile Function) Domain Score

    Week 4

  • Change from Baseline IIEF-EF Domain Score

    Week 8

  • Change from Baseline IIEF-EF Domain Score

    Week 12

  • +1 more secondary outcomes

Study Arms (5)

WC3055-01F

EXPERIMENTAL

WC3055 12.5 mg tablet once daily for 12 weeks

Drug: WC3055

WC3055-02F

EXPERIMENTAL

WC3055 25 mg tablet once daily for 12 weeks

Drug: WC3055

WC3055-03F

EXPERIMENTAL

WC3055 50 mg tablet once daily for 12 weeks

Drug: WC3055

WC3055-04F

EXPERIMENTAL

WC3055 75 mg tablet once daily for 12 weeks

Drug: WC3055

WC3055-07P

PLACEBO COMPARATOR

Placebo tablet once daily for 12 weeks

Other: Placebo

Interventions

WC3055DRUG

12.5, 25, 50 or 75 mg dose

WC3055-01FWC3055-02FWC3055-03FWC3055-04F
PlaceboOTHER

Placebo

WC3055-07P

Eligibility Criteria

Age45 Years+
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • History of LUTS for ≥6 months secondary to BPH
  • Total IPSS (International Prostate Symptom Score) ≥ 13 at Screening

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (95)

Warner Chilcott Investigational Study Site

Homewood, Alabama, 35209, United States

Location

Warner Chilcott Investigational Study Site

Huntsville, Alabama, 35801, United States

Location

Warner Chilcott Investigational Study Site

Mobile, Alabama, 36608, United States

Location

Warner Chilcott Investigational Study Site

Chandler, Arizona, 85224, United States

Location

Warner Chilcott Investigational Study Site

Gilbert, Arizona, 85295, United States

Location

Warner Chilcott Investigational Study Site

Glendale, Arizona, 85306, United States

Location

Warner Chilcott Investigational Study Site

Phoenix, Arizona, 85032, United States

Location

Warner Chilcott Investigational Study Site

Laguna Hills, California, 92653, United States

Location

Warner Chilcott Investigational Study Site

Murrieta, California, 92562, United States

Location

Warner Chilcott Investigational Study Site

San Diego, California, 92103, United States

Location

Warner Chilcott Investigational Study Site

San Diego, California, 92108, United States

Location

Warner Chilcott Investigational Study Site

San Diego, California, 92120, United States

Location

Warner Chilcott Investigational Study Site

San Diego, California, 92123, United States

Location

Warner Chilcott Investigational Study Site

Colorado Springs, Colorado, 80922, United States

Location

Warner Chilcott Investigational Study Site

Denver, Colorado, 80211, United States

Location

Warner Chilcott Investigational Study Site

Denver, Colorado, 80220, United States

Location

Warner Chilcott Investigational Study Site

Denver, Colorado, 80239, United States

Location

Warner Chilcott Investigational Study Site

Englewood, Colorado, 80113, United States

Location

Warner Chilcott Investigational Study Site

Parker, Colorado, 80134, United States

Location

Warner Chilcott Investigational Study Site

Middlebury, Connecticut, 06762, United States

Location

Warner Chilcott Investigational Study Site

New Britain, Connecticut, 06052, United States

Location

Warner Chilcott Investigational Study Site

Aventura, Florida, 33180, United States

Location

Warner Chilcott Investigational Study Site

Clearwater, Florida, 33756, United States

Location

Warner Chilcottt Investigational Study Site

Clearwater, Florida, 33761, United States

Location

Warner Chilcott Investigational Study Site

Hialeah, Florida, 33016, United States

Location

Warner Chilcott Investigational Study Site

Jacksonville, Florida, 32207, United States

Location

Warner Chilcott Investigational Study Site

Kissimmee, Florida, 34741, United States

Location

Warner Chilcott Investigational Study Site

Miami, Florida, 33136, United States

Location

Warner Chilcott Investigational Study Site

Miami, Florida, 33173, United States

Location

Warner Chilcott Investigational Study Site

Ocala, Florida, 34471, United States

Location

Warner Chilcott Investigational Study Site

Pembroke Pines, Florida, 33028, United States

Location

Warner Chilcott Investigational Study Site

Tallahassee, Florida, 32308, United States

Location

Warner Chilcott Investigational Study Site

Atlanta, Georgia, 30342, United States

Location

Warner Chilcott Investigational Study Site

Sandy Springs, Georgia, 30328, United States

Location

Warner Chilcott Investigational Study Site

Coeur d'Alene, Idaho, 83864, United States

Location

Warner Chilcott Investigational Study Site

Chicago, Illinois, 60654, United States

Location

Warner Chilcott Investigational Study Site

Evanston, Illinois, 60201, United States

Location

Warner Chilcott Investigational Study Site

Melrose Park, Illinois, 60160, United States

Location

Warner Chilcott Investigational Study Site

Springfield, Illinois, 62703, United States

Location

Warner Chilcott Investigational Study Site

Springfield, Illinois, 62794, United States

Location

Warner Chilcott Investigational Study Site

Anderson, Indiana, 46011, United States

Location

Warner Chilcott Investigational Study Site

Fort Wayne, Indiana, 46825, United States

Location

Warner Chilcott Investigational Study Site

Jeffersonville, Indiana, 47130, United States

Location

Warner Chilcott Investigational Study Site

Muncie, Indiana, 47304, United States

Location

Warner Chilcott Investigational Study Site

Newburgh, Indiana, 47630, United States

Location

Warner Chilcott Investigational Study Site

West Des Moines, Iowa, 50266, United States

Location

Warner Chilcott Investigational Study Site

Overland Park, Kansas, 66202, United States

Location

Warner Chilcott Investigational Study Site

Shreveport, Louisiana, 71106, United States

Location

Warner Chilcott Investigational Study Site

Elkridge, Maryland, 21075, United States

Location

Warner Chilcott Investigational Study Site

Glen Burnie, Maryland, 21061, United States

Location

Warner Chilcott Investigational Study Site

Owing Mills, Maryland, 21117, United States

Location

Warner Chilcott Investigational Study Site

Towson, Maryland, 21204, United States

Location

Warner Chilcott Investigational Study Site

Brookline, Massachusetts, 02445, United States

Location

Warner Chilcott Investigational Study Site

Omaha, Nebraska, 68114, United States

Location

Warner Chilcott Investigational Study Site

Las Vegas, Nevada, 85282, United States

Location

Warner Chilcott Investigational Study Site

Lawrenceville, New Jersey, 08648, United States

Location

Warner Chilcott Investigational Study Site

Albuquerque, New Mexico, 87109, United States

Location

Warner Chilcott Investigational Study Site

Albany, New York, 12208, United States

Location

Warner Chilcott Investigational Study Site

Brooklyn, New York, 11206, United States

Location

Warner Chilcott Investigational Study Site

Garden City, New York, 11530, United States

Location

Warner Chilcott Investigational Study Site

Great Neck, New York, 11021, United States

Location

Warner Chilcott Investigational Study Site

Kingston, New York, 12401, United States

Location

Warner Chilcott Investigational Study Site

New York, New York, 10016, United States

Location

Warner Chilcott Investigational Study Site

Newburgh, New York, 12550, United States

Location

Warner Chilcott Investigational Study Site

Poughkeepsie, New York, 12601, United States

Location

Warner Chilcott Investigational Study Site

Cary, North Carolina, 27518, United States

Location

Warner Chilcott Investigational Study Site

Charlotte, North Carolina, 28210, United States

Location

Warner Chilcott Investigational Study Site

Concord, North Carolina, 28025, United States

Location

Warner Chilcott Investigational Study Site

High Point, North Carolina, 27262, United States

Location

Warner Chilcott Investigational Study Site

Raleigh, North Carolina, 27609, United States

Location

Warner Chilcott Investigational Study Site

Raleigh, North Carolina, 27612, United States

Location

Warner Chilcott Investigational Study Site

Salisbury, North Carolina, 28144, United States

Location

Warner Chilcott Investigational Study Site

Wilmington, North Carolina, 28401, United States

Location

Warner Chilcott Investigational Study Site

Winston-Salem, North Carolina, 27103, United States

Location

Warner Chilcott Investigational Study Site

Cincinnati, Ohio, 45212, United States

Location

Warner Chilcott Investigational Study Site

Cincinnati, Ohio, 45215, United States

Location

Warner Chilcott Investigational Study Site

Cincinnati, Ohio, 45249, United States

Location

Warner Chilcott Investigational Study Site

Columbus, Ohio, 31904, United States

Location

Warner Chilcott Investigational Study Site

Columbus, Ohio, 43212, United States

Location

Warner Chilcott Investigational Study Site

Lyndhurst, Ohio, 44124, United States

Location

Warner Chilcott Investigational Study Site

Bala-Cynwyd, Pennsylvania, 19004, United States

Location

Warner Chilcott Investigational Study Site

Lancaster, Pennsylvania, 17604, United States

Location

Warner Chilcott Investigational Study Site

Reading, Pennsylvania, 19609, United States

Location

Warner Chilcott Investigational Study Site

Warwick, Rhode Island, 02886, United States

Location

Warner Chilcott Investigational Study Site

Charleston, South Carolina, 29407, United States

Location

Warner Chilcott Investigational Study Site

Myrtle Beach, South Carolina, 29572, United States

Location

Warner Chilcott Investigational Study Site

Bristol, Tennessee, 37620, United States

Location

Warner Chilcott Investigational Study Site

Austin, Texas, 78756, United States

Location

Warner Chilcott Investigational Study Site

Dallas, Texas, 75234, United States

Location

Warner Chilcott Investigational Study Site

San Antonio, Texas, 78229, United States

Location

Warner Chilcott Investigational Study Site

Salt Lake City, Utah, 84107, United States

Location

Warner Chilcott Investigational Study Site

Virginia Beach, Virginia, 23462, United States

Location

Warner Chilcott Investigational Study Site

Winchester, Virginia, 22601, United States

Location

Warner Chilcott Investigational Study Site

Mountlake Terrace, Washington, 98043, United States

Location

Warner Chilcott Investigational Study Site

Wauwatosa, Wisconsin, 53226, United States

Location

MeSH Terms

Conditions

Prostatic Hyperplasia

Condition Hierarchy (Ancestors)

Prostatic DiseasesGenital Diseases, MaleGenital DiseasesUrogenital DiseasesMale Urogenital Diseases

Study Officials

  • Herman Ellman, MD

    Warner Chilcott

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 4, 2013

First Posted

September 11, 2013

Study Start

August 1, 2013

Primary Completion

March 1, 2014

Study Completion

April 1, 2014

Last Updated

June 29, 2015

Record last verified: 2015-06

Locations